Background
==========

Calpain (EC 3.4.22.17) is a Ca^2+^-dependent cysteine protease first isolated in 1978, with a pH optimum between 7.0 and 8.0. There are at least 15 distinct calpain genes present in the human genome and several have a number of isoforms (up to 10). Along with the ATP-dependent proteasome, calpain appears to be responsible for the majority of non-lysosomal targeted proteolysis. It is a member of the papain superfamily \[[@B2]\] a group of proteases that includes papain, calpain, streptopain, ubiquitin-specific peptidases and many families of viral cysteine endopeptidases. Calpain is a protein of ancient origin with homologues found in vertebrates, insects, crustaceans, nematodes, fungi, higher plants, *Dictyostelium*, kinetoplastid Protozoa, and bacteria \[[@B2]\] and evolved from a gene fusion event between an N-terminal cysteine protease and a C-terminal calmodulin-like protein, an event predating the eukaryote/prokaryote divergence \[[@B3]\].

The enzyme cleaves preferentially on the C-terminal side of tyrosine, methionine or arginine, preceded by leucine or valine (i.e. P1 = Y, M, or R; P2 = L or V according to the established nomenclature \[[@B4]\]). Calpain occurs either as a heterodimer with a small regulatory subunit and a large catalytic subunit or as the catalytic subunit alone \[[@B5]\]. It has been crystallised and its structure has been solved for several species \[[@B6],[@B7]\]. The active site consists of a conserved triad of cysteine, asparagine and histidine. The catalytic domain is divided into two subdomains (2a and 2b) with the cysteine residue lying in domain 2a and the histidine and asparagine in 2b. Calpain has a natural monomeric protein inhibitor, calpastatin \[[@B8]\]. In the presence of Ca^2+^, calpain undergoes a conformational change, dissociates from or cleaves the associated calpastatin and finally cleaves its own first domain to become fully active.

Substrates of this enzyme appear to be recognised principally by the presence of PEST sequence(s) within the protein \[[@B9],[@B10]\] although exceptions are known \[[@B11]\]. PEST sequences were first described in 1986 \[[@B12]\] and are short subsequences (usually 10 -- 60 residues) within proteins that are bounded by but do not contain basic residues (H, K or R), and are enriched in proline (P), glutamate (E), serine (S), threonine (T) and aspartate (D) residues. An algorithm (the PEST-find score) has been described for assessing the significance of such subsequences: a score of 5 or greater is regarded as significant. PEST sequences are found in \~10% of all cellular proteins in the organisms analysed to date and are typically found in highly regulated proteins. PEST +ve (PEST sequence containing) proteins typically have short half lives (0.5 to 2 hours) in intact cells compared with most other proteins (\>24 hours). In PEST +ve proteins, removal or disruption of the PEST sequence increases the protein\'s half life to more \"normal\" values while insertion or creation of a new PEST sequence within a PEST -ve (PEST sequence free) protein decreases that protein\'s half life to a value typical of a PEST +ve protein.

Two papers describe the effects of calpain inhibitors on *P. falciparum*. The first \[[@B13]\] described the effect of calpain inhibitors on the invasion of erythrocytes. The authors found the inhibitors used were \~100 times as potent (IC~50~\~10^-7^M) than the other protease inhibitors (chymostatin, leupeptin, pepstatin A and bestatin) examined. Erythrocytes normally contain only calpain 2 and it was not clear at the time if the effect of these inhibitors was as a result of inhibition of the parasite\'s and/or of the erythrocyte\'s calpain. This has been clarified recently by Hanspal *et al.*\[[@B14]\] who reinvestigated this effect in calpain 2 knock-out mice. The mouse erythrocytes were shown to have no detectable calpain activity but still supported the invasion and growth of *P. falciparum*in culture. Calpain inhibition again prevented re-invasion. A third paper \[[@B15]\] has shown that removal of Ca^2+^from the growth medium results in growth arrest in the late trophozoite stage and failure to invade erythrocytes -- findings consistent with a role for calpain in the parasite life cycle. With the recent publication of the entire genome \[[@B16]-[@B18]\] a search for the calpain and calpastatin genes or their homologs and PEST +ve proteins was undertaken to investigate this further.

Methods
=======

The flat files (version 2) were downloaded from the PlasmoDB \[[@B19]\] web site <http://www.plasmodb.org/>. The gene coordinates extracted and then used to build a database of the genes. Multiple errors were found in the annotation including an anomalous start (AAA, CAC, GTA, TAG) and termination codons (AAT, ATA, AAG, CTT, GAA, GGG, TTC, TTT), introns of length 2 and 5 bases, unusual intronic splice sites (TA, TT), introns with exceptionally high GC content (up to 44%) and the absence of a number experimentally known genes. In view of these findings, the alternative annotation of chromosome 2 \[[@B20]\], as revised in September 2002 <http://www.wehi.edu.au/MalDB-www/chr2list.html/>, was used.

The PEST score was calculated with the standard algorithm \[[@B12]\]. Sequences of 10+ residues bounded by, but not containing basic residues (H, K or R), are first identified. The mole percent (MP) of this subsequence is then determined after subtracting one mole equivalent of P, E/D and S/T. The normalised hydrophobicity value is the value of the Kyte-Doolittle index \[[@B21]\] for that residue multiplied by 10 plus 45, giving values between 0 and 90. Stellwagen <http://emb1.bcc.univie.ac.at/embnet/tools/bio/PESTfind/> has suggested that a value of 58 for tyrosine rather than 32 as originally given gives a more reliable PEST score: the former value was used here. The average hydrophobicity (H~o~) of a subsequence is determined by summing the MP of each residue and its normalised hydrophobicity value. The PEST-find score is 0.55 (MP) - 0.5 (H~o~). (The original paper has a misprint with PEST-find = 0.5 (MP) - 0.5(H~o~))

Results
=======

The revised annotation of chromosome 2 \[[@B20]\] predicts 206 protein-encoding genes. Forty-four PEST sequences with scores \> 5 were found with lengths varying from 12 to 94 (30.3 ^+^/-19.9) amino acids in 27 (13.1%) proteins. The proteins fall into four groups (a) hypothetical proteins -- 4 (b) DNA binding proteins -- 2 (origin recognition complex subunit 5 and chromatin-binding protein) (c) metabolic proteins -- 3 (a phosphatase, ribosome releasing factor, ATP-dependent acyl-CoA synthetase) and (d) cell surface associated proteins -- 18 (erythrocyte membrane proteins (EMP) 1 and 3, rifins, merozoite surface proteins (MSP) 2 and 5, serine-repeat antigens, transmission blocking target antigen pfs230 and two predicted secreted proteins). The PEST sequences occur throughout proteins with some bias towards the N-terminal end (60% are found in the first half). The PEST +ve proteins had significantly lower predicted pIs (6.63 and 8.13 respectively: t = 3.86, p \< 0.0005) and were significantly longer (1181 and 731 amino acids respectively: t = 2.91, p \< 0.004) than the average. 18 (66.7%) of the PEST +ve proteins have introns, a figure slightly higher than the mean (57.5%). There was no significant difference in the number of introns per protein (1.12 and 1.32, t = -0.16, p \> 0.8).

On chromosome 13, a putative calpain gene (MAL13P1.310) containing a single intron was found. This gene has been discussed in a paper by Wu *et al*. \[[@B22]\]. The gene is unusually large (2047 residues) and has a biologically implausible \"intron\" that appears to have been created to avoid an unrecognised frameshift \[see [Additional file: 1](#S1){ref-type="supplementary-material"}\]. The 5\' end of the gene contains a low-complexity region and is more than twice the size of other known calpains (generally 600 -- 800 residues). The catalytic domain is the only part of the enzyme with homology with the vertebrate enzymes and in the *P. falciparum*gene this domain is unusually distant from the N-terminus (residues 1002--1470): in other organisms the active site lies within 150 residues of the N-terminus. It seems probable that a fusion event has occurred at the original 5\' end of the calpain gene with a second, to date, unidentified gene. If activation of the *P. falciparum*calpain is similar to that in other organisms, the 5\' domain would be removed during activation and this new element may be responsible for the selective toxicity of the inhibitors or may play some regulatory role.

Discussion
==========

The errors in the published genome were unexpected. A re-annotation of the genome will shortly be completed and it is intended that it will be possible to compare the two annotations (Huestis R., personal communication).

PEST sequences have not been previously described in *P. falciparum*and the sequences found here appear to be very similar to those known in other organisms. The presence of PEST sequences in hypothetical proteins, DNA-binding proteins \[[@B23]\] and proteins involved in intermediary metabolism was expected, while the finding that the majority of PEST +ve sequences were surface exposed proteins was not. The greater length and the lower predicted pI of the PEST +ve proteins and locational bias of the PEST sequences towards the N-terminus are consistent with earlier findings \[[@B12]\].

Several families of surface exposed proteins are present in chromosome 2: PEST sequences were found in all *Pf*EMPs, MSP 2 and 5, a subset of SERA antigens (6 of 8) and rifins (2 of 7). Cytoadherence-linked asexual genes (CLAGs) and sub-telomeric variable open-reading frames (STEVORs) were all PEST -ve. The presence of PEST sequences in a subset of SERA and rifins is suggestive of differential processing or cellular turnover and may shed some light on the reason for the large number of these genes in the genome.

The presence of PEST sequences in surface exposed proteins prompted a search for these sequences in other proteins known to be involved in merozoite invasion. MSP-1 and -2, the SERAs, and erythrocyte binding antigen (EBA)-175 are PEST +ve while apical membrane antigen (AMA)-1, rhoptry associated protein (RAP)-1, -2 and -3, MAEBL, merozoite capping protein-1 and acidic/basic repeat antigen (ABRA) are PEST -ve. Spectrin, band 4.1 and ankyrin are PEST +ve erythrocyte proteins known to be bound by *P. faciparum*merozoites during the invasion process \[[@B25]\]. Band 3, another PEST +ve erythrocyte protein, is eliminated from the site of contact with the merozoite \[[@B26]\]. The involvement of calpain in other cell fusion reactions \[[@B24]\] and the presence of PEST +ve membrane proteins suggest that this system may be involved in cell adhesion processes in *P. falciparum*.

As the parasite progresses from the trophozoite to the schizont stage, there is a thirty-fold increase in the level of transcription of calpain \[[@B22]\]. The erythrocyte normally maintains a submicromolar intracellular Ca^2+^concentration which rises thirty-fold as the parasite matures. \[[@B27]\] Given the presence of a PEST sequence in DNA origin recognition complex protein and the effects on Ca^2+^removal on trophozoite-to-schizont progression, it is tempting to speculate that the lack of Ca^2+^may inhibit calpain activation and that this is responsible for the effects seen here \[[@B28]-[@B32]\]. Bearing in mind a report for a central role for falcipain 1 in merozoite biology \[[@B33]\], the increase in transcriptional levels seen in the schizont and the effect of inhibitors on erythrocyte invasion suggest that calpain too may play a role here.

The *P. falciparum*calpain gene differs significantly from those found to date in vertebrates and this may partly explain the selective toxicity of the inhibitors. There are many calpain inhibitors presently available and the majority of these are small peptides that can be freeze-dried and stored at room temperature. Several have been used in Phase 2 human trials for treatment of myocardial infarction, stroke and cancer. Given the need for novel drugs to treat malaria, the selective toxicity of these inhibitors, several known crystal structures and the possibility of recognising probable target proteins and gene sequence, these agents may be worth exploring further.
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###### 

PEST sequences on chromosome 2.

  Gene ID    Annotation                                                            Sequence start\*   Sequence end\*   PEST score
  ---------- --------------------------------------------------------------------- ------------------ ---------------- ------------
  PFB0010w   tigr pfemp1                                                           1202               1213             6.40
  PFB0010w   tigr pfemp1                                                           815                831              6.79
  PFB0010w   tigr pfemp1                                                           917                948              8.25
  PFB0010w   tigr pfemp1                                                           736                759              5.92
  PFB0010w   tigr pfemp1                                                           764                796              25.89
  PFB0030c   tigr rifin                                                            22                 36               7.10
  PFB0040c   tigr rifin                                                            30                 56               5.04
  PFB0095c   pfemp3 tigr                                                           526                541              5.73
  PFB0095c   pfemp3 tigr                                                           735                755              5.76
  PFB0250w   tigr hypothetical protein tigr merozoite surface antigen              621                635              15.65
  PFB0300c   msp-2 tigr merozoite surface antigen                                  41                 100              5.46
  PFB0305c   msp-5 (egf domain) tigr merozoite surface antigen                     109                128              12.31
  PFB0305c   msp-5 (egf domain) tigr sera antigen/papain-like                      135                168              9.93
  PFB0330c   protease with active cys vbc sera antigen/papain-like                 40                 68               10.38
  PFB0335c   protease with active cys vbc sera antigen/papain-like                 100                130              6.09
  PFB0335c   protease with active cys vbc sera antigen/papain-like                 144                163              9.86
  PFB0335c   protease with active cys vbc sera antigen/papain-like                 259                275              12.43
  PFB0335c   protease with active cys tigr sera antigen/papain-like                487                502              11.12
  PFB0340c   protease with active cys tigr sera antigen/papain-like                21                 89               7.04
  PFB0345c   protease with active ser tigr sera antigen/papain-like                789                853              12.88
  PFB0345c   protease with active ser tigr sera antigen/papain-like                71                 95               18.98
  PFB0345c   protease with active ser tigr sera antigen/papain-like                142                164              7.91
  PFB0350c   protease with active ser tigr sera antigen/papain-like                21                 37               7.05
  PFB0350c   protease with active ser tigr sera antigen/papain-like                70                 110              6.80
  PFB0350c   protease with active ser vbc sera antigen/papain-like                 50                 63               11.42
  PFB0360c   protease with active ser tigr phosphatase (acid phosphatase family)   867                888              9.78
  PFB0380c   tigr ribosome releasing factor                                        332                400              6.69
  PFB0390w   (oo tp) tigr predicted membrane                                       123                216              21.33
  PFB0395w   associated protein tigr transmission blocking                         222                235              9.06
  PFB0405w   target antigen pfs230                                                 1601               1638             8.96
  PFB0460c   vbc qimr hypothetical protein                                         1835               1852             15.52
  PFB0560w   vbc hypothetical protein tigr predicted secreted protein              3631               3654             11.91
  PFB0570w   (thrombospondin domain) vbc predicted secreted                        44                 74               6.52
  PFB0675w   protein tigr ATP-dept. acyl-coa                                       338                354              9.43
  PFB0685c   synthetase (tp)                                                       646                661              8.69
  PFB0700c   tigr hypothetical protein tigr origin recognition cmplx               692                767              12.25
  PFB0720c   subunit 5 (ATPase) tigr chromatin-binding protein                     194                226              17.27
  PFB0875c   (ski/snw family)                                                      141                165              8.91
  PFB0970c   vbc hypothetical protein                                              230                246              10.43
  PFB0970c   vbc hypothetical protein                                              282                300              7.08
  PFB1055c   tigr pfemp1 var                                                       822                890              24.33
  PFB1055c   tigr pfemp1 var                                                       2138               2153             5.90
  PFB1055c   tigr pfemp1 var                                                       1673               1694             15.59

\* Residue number within sequence of polypeptide
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